Attached files
| file | filename |
|---|---|
| EX-10.70 - EX-10.70 - Seagen Inc. | d515764dex1070.htm |
| EX-32.2 - EX-32.2 - Seagen Inc. | d515764dex322.htm |
| EX-32.1 - EX-32.1 - Seagen Inc. | d515764dex321.htm |
| EX-31.2 - EX-31.2 - Seagen Inc. | d515764dex312.htm |
| EX-31.1 - EX-31.1 - Seagen Inc. | d515764dex311.htm |
| EX-21.1 - EX-21.1 - Seagen Inc. | d515764dex211.htm |
| EX-10.14 - EX-10.14 - Seagen Inc. | d515764dex1014.htm |
| EX-10.12 - EX-10.12 - Seagen Inc. | d515764dex1012.htm |
| 10-K - 10-K - Seagen Inc. | d515764d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-212688, 333-204331, 333-197992, 333-188446, 333-176144, 333-168672, 333-148188, 333-56670) and Form S-3 (No. 333-222793) of Seattle Genetics, Inc. of our report dated February 14, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 14, 2018